Inventor · disambiguated record
David Markovitz
Also filed as: MARKOVITZ DAVID · MARKOVITZ DAVID M
9 granted patents·4 pending applications·10 citations·filing 2001–2023
80Inventor score
Top patents by PatentIndex Score
13 records- 0186US11760786B2Chimeric antigen receptors targeting abnormal glycobiologyUNIV MICHIGAN REGENTS·Filed 2020·Granted Sep 19, 2023·2 cites·13 claims
- 0279US12428463B2Chimeric antigen receptors targeting abnormal glycobiologyUNIV MICHIGAN REGENTS·Filed 2023·Granted Sep 30, 2025·0 cites·13 claims
- 0372US8865867B2Lectins and uses thereofMARKOVITZ DAVID·Filed 2011·Granted Oct 21, 2014·2 cites·7 claims
- 0470US7691582B2Methods of secretory vimentin detection and modulationUNIV MICHIGAN·Filed 2003·Granted Apr 6, 2010·5 cites·9 claims
- 0559US9481717B2Lectins and uses thereofUNIV MICHIGAN REGENTS·Filed 2014·Granted Nov 1, 2016·0 cites·3 claims
- 0656US7052676B2Methods for inhibition of HIV replication using a small molecule inhibitorUNIV MICHIGAN·Filed 2001·Granted May 30, 2006·1 cites·5 claims
- 0743US10450355B2Lectins and uses thereofUNIV MICHIGAN REGENTS·Filed 2015·Granted Oct 22, 2019·0 cites·15 claims
- 0842US7641902B2Compositions and methods for detecting cancer and for inhibiting metastasisUNIV MICHIGAN·Filed 2006·Granted Jan 5, 2010·0 cites·5 claims
- 0942US2008261216A1HERV Group II Viruses In Lymphoma And CancerUNIV MICHIGAN·Filed 2007·Application pending·0 cites
- 1041US2002137704A1Methods of inhibiting host-cell mediated viral replicationFiled 2001·Application pending·0 cites
- 1139US2015246067A1Antiviral treatment of lymphoma and cancerUNIV MICHIGAN·Filed 2015·Application pending·0 cites
- 1237US8652467B2Dek protein compositions and methods of using the sameMARKOVITZ DAVID M·Filed 2006·Granted Feb 18, 2014·0 cites·9 claims
- 1334US2012135950A1Antiviral treatment of lymphoma and cancerKAPLAN MARK H·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Markovitz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →